Document is current
Any future updates will be listed below
-
Authors
Dekeukeleire, Max
Vandenheuvel, Dieter
Khondee, Tippapron
Delanghe, Lize
Van Rillaer, Tim
Thys, Sofie
Timmermans, Jean-Pierre
Lebeer, Sarah
Spacova, Irina
-
Funding
Funding for this research was provided by:
Agentschap Innoveren en Ondernemen (HBC.2020.2287, HBC.2020.2873)
European Research Council (Lacto-Be: 852600)
Bijzonder Onderzoeksfonds, UAntwerpen, Belgium (BOF KP 53399)
Fonds Wetenschappelijk Onderzoek (1277222N)
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 21 July 2025
First Online: 20 August 2025
Declarations
:
: The PhD research of M.D. is funded by VLAIO through a Baekeland mandate in collaboration with Metatecta NV (BioOrg/Living Solutions). Living Technologies cvba provided part of the bacterial strains (Bacillus velezensis AMBY1 and AMBY9, Bacillus licheniformis AMBY3, Bacillus subtilis AMBY7 and AMBY8, Bacillus pumilus AMBY10 and AMBY11) tested in this project, but this company was not involved in the design and execution of the experiments in this manuscript. S.L. serves on the academic board of International Scientific Association for Probiotic and Prebiotics (ISAPP) (www.isappscience.org). I.S. and D.V. also declare having received funding from ISAPP, and I.S. from the International Probiotics Association (IPA), to attend conferences. S.L., I.S. and D.V. have received research funding from companies not related to this paper. L.D. was funded by VLAIO through a Baekeland mandate in collaboration with Yun NV. Yun NV was not involved in this study. The remaining authors have no conflicts of interest to declare related to this paper.
